|
⚲
|
| Thomas Beck | |
|---|---|
| Firm | |
| Address | 826 North Plankinton Ave Ste 400 Milwaukee, WI 53203 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Promentis Pharmaceuticals Inc | 021-356545 | Director | 2.5 M of 6.0 M |
||
| Akriveia Therapeutics LLC | 021-304462 | Director | 3.0 M of 22.5 M |
||
| Mersana Therapeutics Inc | 021-265754 | Director | 33.1 M of 33.1 M |
||
| Akriveia Therapeutics LLC | 021-265056 | Director | 4.5 M of 7.5 M |
||
| Symbiomix Therapeutics LLC | 021-262464 | Director | 6.0 M of 6.0 M |
||
| R2I Holdings LLC | 021-253715 | Executive Officer | 3.6 M of 3.6 M |
||
| R2I Holdings LLC | 021-235879 | Executive Officer | 6.4 M of 6.4 M |
||
| Mersana Therapeutics Inc | 021-235062 | Director | 10.1 M of 35.5 M |
||
| Symbiomix Therapeutics LLC | 021-220646 | Director | 19.5 M of 32.5 M |
||
| Dimension Therapeutics Inc | 021-206529 | Executive Officer | 24.5 M of 24.5 M |
||
| Mersana Therapeutics Inc | 021-204292 | Director | 14.5 M of 14.5 M |
||
| Mersana Therapeutics Inc | 021-182471 | Director | 12.5 M of 27.0 M |
||
| Mersana Therapeutics Inc | 021-158771 | Director | 10.0 M of 10.0 M |
||
| Mersana Therapeutics Inc | 021-121447 | Director | 2.5 M of 3.5 M |
||
| Vicept Therapeutics Inc | 021-133791 | Director | 15.8 M of 15.8 M |
||